Clinical trials
Completed Phase 1 Carcinoma, Transitional Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 12 |
| 2019 | 7 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 54 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Xencor, Inc. | 4 |
| H. Lee Moffitt Cancer Center and Research Institute | 3 |
| Bristol-Myers Squibb | 2 |
| Eisai Co., Ltd. | 2 |
| Incyte Corporation | 2 |
| Ludwig Institute for Cancer Research | 2 |
| Tempest Therapeutics | 2 |
| The Netherlands Cancer Institute | 2 |
| ALX Oncology Inc. | 1 |
| Adaptimmune | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 54 |
| Carcinoma, Non-Small-Cell Lung | 24 |
| Melanoma | 19 |
| Squamous Cell Carcinoma of Head and Neck | 19 |
| Carcinoma, Renal Cell | 15 |
| Urinary Bladder Neoplasms | 15 |
| Carcinoma, Hepatocellular | 10 |
| Colorectal Neoplasms | 9 |
| Triple Negative Breast Neoplasms | 9 |
| Uterine Cervical Neoplasms | 9 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.